arrow
K

Karin Birkenkamp-Demtröder

Aarhus University Hospital
H指数:40
被引数:6,377

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ctDNA-Guided Immunotherapy following Radical Cystectomy for Muscle-Invasive Bladder Cancer: Results from the TOMBOLA Trial

肌层浸润性膀胱癌根治性膀胱切除术后ctDNA引导的免疫治疗: 来自TOMBOLA试验的结果

2026-01-140
OAAI
Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma

全基因组突变分析用于尿路上皮癌患者循环肿瘤DNA的肿瘤知情检测

2024-10-012
OA
Identification of bladder cancer patients that could benefit from early post-cystectomy immunotherapy based on serial circulating tumour DNA (ctDNA) testing: Preliminary results from the TOMBOLA trial

基于系列循环肿瘤DNA(ctDNA)检测,识别可能从早期根治性膀胱切除术后免疫治疗中获益的膀胱癌患者:TOMBOLA试验的初步结果

2024-09-013
PRE
Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer

田间癌变与膀胱癌的肿瘤发展,T细胞衰竭和临床结局有关

2024-01-0114
OA
Comprehensive genomic characterization of early-stage bladder cancer from 438 patients by whole genome- and exome sequencing
2023-04-040
PRE
Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guerin Failure in Patients with Non-muscle-invasive Bladder Cancer
2022-12-0126
OA
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

整合的多组学分析确定非肌层浸润性膀胱癌的预后分子亚型

2021-04-16185
OAAI
Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma
2019-07-015
PRE